Concepedia

Author

Joseph Stephenson

The University of Texas Health Science Center at San Antonio

Also Known As

J Stephenson, J. Stephenson, Joseph A. Stephenson, Jr., Joseph Stephenson

27

Publications

855

Citations

9

H-Index

24

Concepts

All Affiliations

The University of Texas Health Science Center at San AntonioBrooke Army Medical CenterWilford Hall Ambulatory Surgical Center
JS

About

Joseph Stephenson is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, pharmacology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

233

2

Immunology

2

2

215

3

Cell Biology

1

1

147

4

Cellular Physiology

1

1

147

5

Molecular Biology

1

1

147

Joseph Stephenson

×

9

Publications

809

Citations

9

H-Index

YearCitations

Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

Charles M. Rudin, John T. Poirier, Neil Senzer,

Clinical Cancer Research

2011

153

Combined modalities of resistance in etoposide-resistant human KB cell lines.

Peter J. Ferguson, M. H. FISHER, Joseph Stephenson,

PubMed

1988

147

Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

Eric K. Rowinsky, Lee Smith, Y M Wang,

Journal of Clinical Oncology

1998

146

Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value

Jordan Chamberlin, Madison Kocher, Jeffrey Waltz,

BMC Medicine

2021

132

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

Ronald Drengler, John G. Kuhn, Larry J. Schaaf,

Journal of Clinical Oncology

1999

94

Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity

Johann S. de Bono, Sun Young Rha, Joseph Stephenson,

Annals of Oncology

2004

68

Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel

Manuel Hidalgo, Cheryl Aylesworth, Lisa A. Hammond,

Journal of Clinical Oncology

2001

40

Troxacitabine, an <scp>l</scp>-Stereoisomeric Nucleoside Analog, on a Five-Times-Daily Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies

Johann S. de Bono, Joseph Stephenson, Sharyn D. Baker,

Journal of Clinical Oncology

2002

18

Complete Remissions Observed in Acute Myeloid Leukemia Following Prolonged Exposure to SGN-33 (lintuzumab), a Humanized Monoclonal Antibody Targeting CD33.

Azra Raza, Joseph G. Jurcic, Gail J. Roboz,

Blood

2007

11

Page 1